Ines Nikolovski
Overview
Explore the profile of Ines Nikolovski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
467
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charbel C, Andrieu P, Soliman M, Woo S, Zheng J, Capanu M, et al.
Radiol Imaging Cancer
. 2024 Mar;
6(2):e230063.
PMID: 38456787
Purpose To investigate the prevalence of , and mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these...
2.
Andrieu P, Nikolovski I, Juluru K, Sadowski E, Gangai N, Zheng J, et al.
AJR Am J Roentgenol
. 2023 Jul;
221(6):760-772.
PMID: 37436033
Imaging reports that consistently document all disease sites with a potential to increase surgical complexity or morbidity can facilitate ovarian cancer treatment planning. The aims of this study were to...
3.
Vazquez-Garcia I, Uhlitz F, Ceglia N, Lim J, Wu M, Mohibullah N, et al.
Nature
. 2022 Dec;
612(7941):778-786.
PMID: 36517593
High-grade serous ovarian cancer (HGSOC) is an archetypal cancer of genomic instability patterned by distinct mutational processes, tumour heterogeneity and intraperitoneal spread. Immunotherapies have had limited efficacy in HGSOC, highlighting...
4.
Boehm K, Aherne E, Ellenson L, Nikolovski I, Alghamdi M, Vazquez-Garcia I, et al.
Nat Cancer
. 2022 Jun;
3(6):723-733.
PMID: 35764743
Patients with high-grade serous ovarian cancer suffer poor prognosis and variable response to treatment. Known prognostic factors for this disease include homologous recombination deficiency status, age, pathological stage and residual...
5.
Wibmer A, Lefkowitz R, Lakhman Y, Chaim J, Nikolovski I, Sala E, et al.
Clin Genitourin Cancer
. 2022 May;
20(4):319-325.
PMID: 35618599
Introduction/background: Magnetic resonance imaging (MRI) misses a proportion of "clinically significant" prostate cancers (csPC) as defined by histopathology criteria. The aim of this study was to analyze whether long-term oncologic...
6.
Fernandes M, Nikolovski I, Long Roche K, Lakhman Y
Radiology
. 2022 May;
304(3):516-526.
PMID: 35608442
A 60-year-old woman presented with intermittent abdominal pain, an elevated serum CA-125 level, and an abnormal CT examination and was ultimately diagnosed with advanced-stage high-grade serous ovarian cancer. Key tumor...
7.
Wibmer A, Nikolovski I, Chaim J, Lakhman Y, Lefkowitz R, Sala E, et al.
Radiology
. 2021 Dec;
302(3):595-602.
PMID: 34931855
Background It is unknown how the imperfect accuracy of MRI for local staging of prostate cancer relates to oncologic outcomes. Purpose To analyze how staging discordances between MRI and histopathologic...
8.
Gleeson J, Nikolovski I, Dinatale R, Zucker M, Knezevic A, Patil S, et al.
Clin Cancer Res
. 2021 Mar;
27(10):2910-2919.
PMID: 33658299
Purpose: Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a rare, aggressive form of RCC associated with hereditary leiomyomatosis and RCC syndrome. Evidence for systemic therapy efficacy is lacking. Experimental Design:...
9.
Nikolovski I, Carlo M, Chen Y, Vargas H
Cancer Imaging
. 2021 Feb;
21(1):24.
PMID: 33608050
Backgound: Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a subtype of RCC that is increasingly recognized pathologically. The aim of this study was to evaluate the imaging features of FH-RCC...
10.
Wibmer A, Chaim J, Lakhman Y, Lefkowitz R, Nincevic J, Nikolovski I, et al.
J Urol
. 2020 Nov;
205(4):1055-1062.
PMID: 33207133
Purpose: We investigated whether T2-weighted magnetic resonance imaging findings could improve upon established prognostic indicators of metastatic disease and prostate cancer specific survival. Materials And Methods: For a cohort of...